Learn · Clinical Labs · Medical Devices · Digital Health
Does Professional Liability Insurance Cover a Regulatory Fine?
Professional liability answers third-party error claims. Fines from the FDA, OCR, or CMS are government penalties, and most E&O policies exclude them.
3 min read · Clinical Labs · Medical Devices · Digital Health · May 25, 2026
Jump to section
Usually not. Professional liability answers claims by third parties alleging an error or omission in your professional services. A regulatory fine is a different animal: a penalty imposed by a government agency, the FDA, OCR, or CMS, acting in its enforcement capacity. Most professional liability policies explicitly exclude fines and penalties, so a company that assumes its E&O will absorb a regulatory hit is usually wrong about the one exposure it most wants covered.
What Professional Liability Is For
Professional liability, often written as errors and omissions, responds when a third party claims your professional work fell short and caused them harm or loss: a client, a patient, a customer alleging negligence in the service you performed. It pays to defend that claim and, where you are liable, to indemnify it. The structure assumes a private claimant seeking damages. That is the lane the policy is built for, and across life sciences it is the line that answers a testing error, a flawed clinical recommendation, or a failed technology service.
A regulatory fine does not fit that structure. The claimant is not a private party seeking damages; it is the government imposing a penalty for a violation. The policy that answers a negligence claim was not designed to pay a government penalty, and the wording typically says so directly.
Why Fines and Penalties Sit Outside the Policy
There are two reasons regulatory fines fall outside professional liability. The first is the exclusion: most E&O forms carve out fines, penalties, and sanctions explicitly. The second is insurability itself, which varies by jurisdiction. Some penalties are uninsurable as a matter of public policy, on the theory that letting insurance absorb a punitive government sanction would blunt its deterrent purpose. So even where a policy is silent, the law of the jurisdiction may prevent coverage of the penalty.
This matters because the cost can be large and uninsured at the same time. An OCR action over an unmanaged security risk, an FDA enforcement action over post-market obligations, or a CMS billing penalty can each arrive as a first-party government demand that the professional liability policy was never going to pay. The OCR version of this is the exact pattern in OCR risk-management enforcement for digital health, where the penalty for failing to act on a known risk can fall outside a standard policy.
What Does Respond, and How
The piece that often is available is regulatory defense: the cost of responding to an investigation or proceeding, as distinct from the penalty itself. Many specialty policies include a regulatory defense sub-limit, and for a regulated company that sub-limit is worth reading closely, because defense cost arrives whether or not a penalty is ever imposed. Where the exposure is management-level or enforcement-driven, the line that tends to carry regulatory defense is management liability rather than professional liability, and for a device company the regulatory dimension shows up in the QMSR-era program as much as anywhere. For a HIPAA-regulated company, the defense-versus-penalty distinction is part of the structure in cyber coverage for a HIPAA-regulated company.
The practical takeaway is to separate two questions the policy treats very differently: does the program pay to defend a regulatory matter, and does it pay the penalty if one lands. The answer to the first is often yes, within a sub-limit. The answer to the second is often no.
What to Do Now
Do not assume your professional liability policy stands behind a regulatory fine. Read the policy for its fines-and-penalties exclusion, find where regulatory defense lives in your program and what its sub-limit is, and confirm whether any penalty coverage you do have is insurable where you operate. The strongest protection is upstream: the documentation and controls that keep a violation from being found in the first place, because that is the exposure no policy fully cures.
Before your next renewal, separate regulatory defense from penalty exposure across your program and confirm which agency actions each policy would actually answer. A specialty review through Tower Street Insurance can show where your regulatory exposure is defended, where a penalty would fall to the company, and how to close the gap that matters most.
Related reading
Further coverage on this segment.
Clinical Labs · Medical Devices · Digital Health
What Insurance Does a Digital Pathology Company Need?
Clinical Labs · Medical Devices · Digital Health
What Insurance Do Government Contracts Require from Life Sciences Companies?
Clinical Labs · Medical Devices · Digital Health
What Insurance Does a Life Sciences Company Need at the Seed Stage?
Coverage review
Have a specific question about your coverage?
A 30-minute structural review of your current coverage. You receive a gap analysis specific to your segment, stage-appropriate benchmarks, and a working document you can use heading into renewal.